Safety and Efficacy of CDCA in CTX Chenodeoxycholic Acid (CDCA) in Patients Affected by Cerebrotendinous Xanthomatosis (CTX)
NCT05499026 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 28
Last updated 2022-08-12
Summary
Retrospective study of CTX patients to investigate the safety and clinical efficacy of Chenodeoxycholic Acid
Conditions
- Cerebrotendinous Xanthomatoses
Interventions
- DRUG
-
Chenodeoxycholic Acid
Bile acid
Sponsors & Collaborators
-
Leadiant Biosciences Ltd.
lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-12-09
- Primary Completion
- 2015-06-03
- Completion
- 2015-06-03
More Related Trials
-
Cholic Acid for Hepatic Steatosis in Lipodystrophy
NCT00457639 ·Status: COMPLETED ·Phase: PHASE2
-
Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies
NCT02214160 ·Status: COMPLETED ·Phase: PHASE2
-
Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy Subjects
NCT04053023 ·Status: COMPLETED ·Phase: PHASE1
-
FBCx (Alpha-CD) Mechanism of Action Trial
NCT02999620 ·Status: COMPLETED ·Phase: NA
-
Clinical Outcome of Triheptanoin Treatment in Patients With Long-chain Fatty Acid Oxidation Disorders (LC-FAOD) Treated Under Expanded Access Program
NCT03768817 ·Status: COMPLETED
-
An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
NCT01528917 ·Status: COMPLETED
-
Safety Study of CNT-01 in Patients With Idiopathic TGCV
NCT02502578 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Biliary Excretion of Conjugated Bile Acids in Humans Measured by 11C-cholylsarcosine PET/CT
NCT01879735 ·Status: COMPLETED ·Phase: PHASE1
-
PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Cholestatic Disorders in Patients with Genetic Liver Disorders and Healthy Individuals
NCT06610695 ·Status: ENROLLING_BY_INVITATION
-
Study of Bile Acids in Patients With Peroxisomal Disorders
NCT00004442 ·Status: TERMINATED ·Phase: NA
-
Injection Techniques of Collagenase Clostridium Histolyticum (CCH) for the Treatment of EFP (Cellulite)
NCT03632993 ·Status: COMPLETED ·Phase: PHASE2
-
Changes in Bile Acid Homeostasis and Stool Habits After Cholecystectomy
NCT03168555 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic Fibrosis
NCT00004441 ·Status: COMPLETED ·Phase: NA
-
Intralumenal Effects on Cholesterol Absorption/Synthesis
NCT00328211 ·Status: COMPLETED ·Phase: NA
-
Impact Of Choline in Patients With NAFLD
NCT05200156 ·Status: UNKNOWN ·Phase: NA
-
GlycoCholic Acid Treatment for Patients With Inborn Errors in Bile Acid Synthesis
NCT01589523 ·Status: COMPLETED ·Phase: PHASE3
-
ButyraGen™, Short Chain Fatty Acids and Gut Microbiome
NCT05601635 ·Status: COMPLETED ·Phase: NA
-
Effect of Bezafibrate on Muscle Metabolism in Patients With Fatty Acid Oxidation Defects
NCT00983788 ·Status: COMPLETED ·Phase: PHASE2
-
Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children
NCT01529268 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Validation of Stimulated ∆FGF19 for Diagnosing Bile Acid Diarrhoea
NCT03059537 ·Status: COMPLETED ·Phase: PHASE4
-
Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients
NCT02430077 ·Status: COMPLETED ·Phase: PHASE2
-
CoA-Z in Pantothenate Kinase-associated Neurodegeneration (PKAN)
NCT04182763 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Effect of Injection Lypolysis (Lipodissolve) Treatments to Reduce Body Fat
NCT00757081 ·Status: COMPLETED ·Phase: NA
-
Clinical Study on the Safety of CNT-02 for TGCV and NLSD-M
NCT02830763 ·Status: TERMINATED ·Phase: NA
-
The Effect of Bezafibrate on the Level of Very Long Chain Fatty Acids (VLCFA) in X-linked Adrenoleukodystrophy (X-ALD)
NCT01165060 ·Status: COMPLETED ·Phase: NA